Search clinical trials for: TQB2450 Injection Anlotinib Hydrochloride Capsules
Total 1551 results
-
National Cancer Institute (NCI)CompletedRecurrent Childhood Medulloblastoma | Recurrent Childhood Ependymoma | Recurrent Neuroblastoma | Recurrent Osteosarcoma | Recurrent Childhood Rhabdomyosarcoma | Previously Treated Childhood Rhabdomyosarcoma | Recurrent Childhood Soft Tissue Sarcoma | Recurrent Childhood Malignant Germ Cell Tumor | Recurrent... and other conditionsUnited States
-
Anhui Medical UniversityUnknownSelf Efficacy | Drug ToxicityChina
-
Boehringer IngelheimCompletedCarcinoma, Non-Small-Cell LungUnited States, Spain, Taiwan, China, United Kingdom, Denmark, Canada, Korea, Republic of, Germany, Italy, Netherlands, Singapore, Austria, France, Portugal, Greece, India, Mexico, Hungary, Turkey, Argentina, Chile, Ireland
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerItaly
-
Northwell HealthGenentech, Inc.CompletedGlioblastoma Multiforme | Anaplastic AstrocytomaUnited States
-
Northwestern UniversityOSI PharmaceuticalsWithdrawn
-
Alaunos TherapeuticsUnknownAdvanced Solid TumorsUnited States
-
Nanjing Leads Biolabs Co.,LtdRecruiting
-
Luye Pharma Group Ltd.CompletedAdvanced Solid TumorChina
-
NYU Langone HealthCompletedEnd Stage Renal DiseaseUnited States
-
Andrew B Lassman, MDGenentech, Inc.; OSI PharmaceuticalsCompleted
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedMetastatic Skin Squamous Cell Carcinoma | Recurrent Skin Squamous Cell CarcinomaUnited States
-
Montefiore Medical CenterGenentech, Inc.Completed
-
Pasi A. Janne, MD, PhDMassachusetts General Hospital; Dana-Farber Cancer Institute; Beth Israel Deaconess... and other collaboratorsCompletedAdenocarcinoma | Non-small Cell Lung CancerUnited States
-
OSI PharmaceuticalsTerminatedEpendymomaUnited States, Canada, United Kingdom
-
Kyowa Kirin Co., Ltd.CompletedAdvanced/Recurrent Non-small-cell Lung CancerJapan
-
Hoffmann-La RocheCompletedPancreatic CancerAustralia, Hong Kong, Romania, Germany, Russian Federation, United Kingdom, Bulgaria, Malaysia, Latvia, Slovenia, Croatia, Brazil, Italy, Lithuania, India, Mexico, Singapore, Peru, Ukraine
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerBulgaria
-
Hoffmann-La RocheCompletedNon-Small Cell Lung CancerFinland
-
Hoffmann-La RocheCompletedNon-Small Cell Lung CancerItaly, Spain, Netherlands, France, Germany, United Kingdom
-
PfizerTerminatedCarcinoma, Non-Small-Cell Lung | Carcinoma, Squamous Cell | Carcinoma, Large Cell | Carcinoma, Adenosquamous CellUnited States, Bulgaria, Italy, Spain, Ukraine, Belgium, France, Ireland, Korea, Republic of, Poland, Russian Federation, United Kingdom, Hungary, Serbia, Taiwan, Canada, South Africa, Brazil, Romania, Greece, Puerto Rico, Czech Republic and more
-
Hoffmann-La RocheTerminatedNon-Small Cell Lung CancerUnited States, Canada, France, Poland
-
Hellenic Oncology Research GroupUniversity Hospital of CreteCompleted
-
AZ-VUBHoffmann-La RocheUnknownLung Neoplasms | Non-Small Cell Lung Cancer | Adenocarcinoma, Bronchiolo-AlveolarBelgium
-
Medical College of WisconsinCompletedHematologic Diseases | Clostridium Difficile Infection | Oncologic Disorders | Bone Marrow TransplantUnited States
-
Genentech, Inc.Completed
-
National Cancer Institute (NCI)Completed
-
Novartis PharmaceuticalsCompletedRelapsing Multiple ScelrosisUnited States, Austria, Belgium, Croatia, Germany, Taiwan, Canada, Czechia, Spain, Argentina, Australia, Peru, South Africa, United Kingdom, Bulgaria, Latvia, Lithuania, Russian Federation, India, Portugal, Italy, Turkey, Finland, France and more
-
Tasly Pharmaceutical Group Co., LtdRecruiting
-
Hellenic Cooperative Oncology GroupTerminatedAdvanced Non-Small Cell Lung CancerGreece
-
Novartis PharmaceuticalsCompletedRelapsing Multiple SclerosisBelgium, Italy, United States, Croatia, Spain, Netherlands, Switzerland, Thailand, Israel, Czechia, Estonia, Poland, France, Bulgaria, Russian Federation, Germany, Turkey, Slovakia, Australia, Denmark, Greece, Argentina, India, Hungary, United Kingdom and more
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Completed
-
The First Affiliated Hospital with Nanjing Medical...Not yet recruitingTo Evaluate the Efficacy and Safety of Anlotinib Combined With Concurrent Chemoradiotherapy in the Treatment of Locally Advanced Cervical Cancer
-
Fudan UniversityNot yet recruiting
-
The First Affiliated Hospital of Soochow UniversityAffiliated Hospital of Jiangnan University; Chia Tai Tianqing Pharmaceutical... and other collaboratorsUnknownNon-Small-Cell LungChina
-
Daiichi Sankyo, Inc.CompletedNSCLC (Advanced Non-small Cell Lung Cancer)Ukraine, United Kingdom, United States, Bulgaria, Belgium, Germany, Hungary, Austria, Italy, Israel, Lithuania, Romania, Slovenia
-
Daiichi Sankyo, Inc.CompletedAdvanced Non-small Cell Lung Cancer (NSCLC)Korea, Republic of, United States, India, Germany
-
Novartis PharmaceuticalsTerminatedNon-Small Cell Lung CancerItaly, Singapore, Spain, Germany, Korea, Republic of, United States, Belgium, France, Netherlands, Japan
-
Incyte CorporationWithdrawnSolid Tumors and Hematologic Malignancy | NSCLC (Non-small Cell Lung Carcinoma)United States
-
SanofiCompletedCancer | Non-small Cell Lung CancerUnited States
-
Millennium Pharmaceuticals, Inc.Johnson & Johnson Pharmaceutical Research & Development, L.L.C.Terminated
-
UNC Lineberger Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedLung CancerUnited States
-
University of PittsburghCompletedHead and Neck Cancer | Non Small Cell Lung CancerUnited States
-
Astellas Pharma Global Development, Inc.Terminated
-
OSI PharmaceuticalsCanadian Cancer Trials GroupCompletedCarcinoma, Non-small-cell LungCanada, United States, Australia, Singapore, Israel, China, Argentina, Germany, Sweden, Brazil, Chile, Greece, Mexico, New Zealand, Romania, South Africa, Thailand
-
Hoffmann-La RocheCompleted
-
Genentech, Inc.Completed
-
Genentech, Inc.Completed
-
AgennixCompletedLung CancerUnited States, Canada, Chile
-
Astellas Pharma IncOSI PharmaceuticalsCompletedAdvanced Solid TumorsUnited States, United Kingdom